Table 5.
Comparison of liver function biochemical indexes after treatment
| Items | Regorafenib plus DEB-TACE (N = 34) | Regorafenib (N = 42) | χ2 | P value |
|---|---|---|---|---|
| ALT, no. (%) | – | – | ||
| Abnormal (> 40 U/L) | 0 (0.0) | 0 (0.0) | ||
| Normal (≤ 40 U/L) | 34 (100.0) | 42 (100.0) | ||
| AST, no. (%) | – | – | ||
| Abnormal (> 40 U/L) | 0 (0.0) | 0 (0.0) | ||
| Normal (≤ 40 U/L) | 34 (100.0) | 42 (100.0) | ||
| Cholinesterase, no. (%) | – | 0.084 | ||
| Abnormal (> 32,000 U/L or < 4300 U/L) | 5 (14.7) | 1 (2.4) | ||
| Normal (4300–32,000 U/L) | 29 (85.3) | 41 (97.6) |
DEB-TACE drug-eluting bead transarterial chemoembolization, ALT alanine transaminase, AST aspartate aminotransferase
Comparison was determined by Fisher’s exact test